KyungDong Pharm Co., Ltd. releases ‘Solfecin Tablets 5mg, 10mg (Solifenacin Succinate)’, a treatment for overactive bladder symptoms, on July 14, 2017.
Solfecin tablets are an antimuscarinic drug with high selectivity for M3 receptors in the bladder, and have the advantage of having a lower rate of dry mouth compared to existing antimuscarinic drugs. In addition, it shows a greater symptom improvement effect than existing antimuscarinics in reducing urinary urgency, urgency urinary incontinence, and the frequency of urinary incontinence.
It is expected that the launch of Solpecin tablets, along with KyungDong Pharm Co., Ltd.'s Telodine tablets (Tolterodine 2mg), will be helpful in the treatment of patients with overactive bladder.

 

♤ Product Information ♤

Product Name

Solfecin tablets 5mg

Solfecin tablets 10mg

Ingredient content

Solifenacin succinate 5mg

Solifenacin succinate 10mg

Indications

Treatment of overactive bladder symptoms such as urge incontinence, frequent urination, and urinary urgency.

Dosage and usage

Recommended dose: 5mg once a day, increase up to 10mg once a day if necessary

Reimbursement Prices

678 won/tablet

678 won/tablet

Reimbursement Code

648103820

648103830

Packaging unit

30 tablets, 100 tablets

30 tablets, 100 tablets

 

※ Please refer to the product manual for other details such as precautions for use.